- Pharmaceutical companies
- Europe
- France
- Jazz Pharmaceuticals
Jazz Pharmaceuticals in France
Web: https://www.jazzpharma.com/
Address:
-
CityOne 84 quai Charles de Gaulle 69006 Lyon France
Phone: +33 4 37 49 85 85
Other Jazz Pharmaceuticals's locations around the world
Clinical Trials sponsored by Jazz Pharmaceuticals
-
Jazz PharmaceuticalsRekryteringTuberös skleroskomplex associerad neuropsykiatrisk sjukdomFörenta staterna, Storbritannien, Polen
-
Jazz PharmaceuticalsRekryteringParkinsons sjukdom | DarrningFörenta staterna, Spanien, Tyskland, Polen
-
Jazz PharmaceuticalsRekryteringFast tumör | Metastaserande cancer | Avancerad cancerFörenta staterna
-
Jazz PharmaceuticalsRekryteringTuberös skleroskomplex | Dravets syndrom | Lennox Gastauts syndromFörenta staterna
-
Jazz PharmaceuticalsRekrytering
-
Jazz PharmaceuticalsAktiv, inte rekryterandeHER2-uttryckande gastrointestinala cancer, inklusive gastroesofagealt adenokarcinom, gallvägscancer och kolorektal cancerFörenta staterna, Korea, Republiken av, Chile, Kanada
-
Jazz PharmaceuticalsAktiv, inte rekryterandeHER2-uttryckande cancerFörenta staterna, Kanada, Korea, Republiken av
-
Jazz PharmaceuticalsAvslutadAvancerad solid tumör | Metastatisk fast tumör | Urothelial cancer | Dåligt differentierade neuroendokrina karcinom | Homolog rekombinationsbrist-positiva maligniteter AgnostiskFörenta staterna
-
Jazz PharmaceuticalsAvslutadSpasticitet med multipel sklerosSpanien, Förenta staterna, Storbritannien, Tjeckien, Polen
-
Jazz PharmaceuticalsAktiv, inte rekryterande
About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients. We are focused on developing life-changing medicines for people with serious diseases — often with limited or no options — so they can live their lives more fully. By transforming biopharmaceutical discoveries into novel medicines, we are working to give people around the world the opportunity to redefine what’s possible – to make the “small wins” big again. Through continued investment in an evolving and growing research and development focus, we seek solutions for rare or complex diseases, and ensure those solutions are available for the often-overlooked patients who need them. Our approach has allowed us to shepherd new medicines to market – from late-stage discovery through clinical development and regulatory approval. All of these advancements are a reflection of our continued investment in an evolving and growing research and development focus.